EPISODE · Apr 30, 2012 · 12 MIN
Podcast 153: Type 2 diabetes in young people — tough going on the treatment front
from Clinical Conversations · host NEJM Group
About half of adolescents with type 2 diabetes fail treatment with metformin alone within a few years. Things go somewhat better with metformin plus an intensive lifestyle intervention, and better still with the addition of rosiglitazone to metformin — however even the addition of the second drug leads to treatment failure about 40% of the time. What’s to be done? On the basis of the evidence collected by the TODAY investigators, the problem has as many metabolic as social dimensions. Clearly, drugs alone are not the answer here. Dr. Phil Zeitler, the TODAY study chair talks with Clinical Conversations about his surprise at the higher rate of failure with metformin monotherapy among adolescents than among adults, and what lessons this study holds. Links: Physician’s First Watch summary (free) New England Journal of Medicine article (free) New England Journal of Medicine editorial (free) The post Podcast 153: Type 2 diabetes in young people — tough going on the treatment front first appeared on Clinical Conversations.
Embed this episode
What this episode covers
About half of adolescents with type 2 diabetes fail treatment with metformin alone within a few years. Things go somewhat better with metformin plus an intensive lifestyle intervention, and better still with the addition of rosiglitazone to metformin — however even the addition of the second drug leads to treatment failure about 40% of the time. […]
NOW PLAYING
Podcast 153: Type 2 diabetes in young people — tough going on the treatment front
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.